Outcome Evaluation After Fertility Preservation

Launched by CHINESE UNIVERSITY OF HONG KONG · Sep 12, 2023

Keywords

ClinConnect Summary

This clinical trial is studying different methods to help preserve fertility for patients facing cancer or other medical treatments that could harm their ability to have children in the future. The goal is to understand how well these fertility preservation strategies work and to identify any factors that might influence the chances of having a baby later on.

Eligible participants are individuals between the ages of 0 and 50 who are undergoing treatments that could damage their fertility, such as certain surgeries or high-risk medications. If you join the study, you can expect to receive support and information regarding your fertility options. It’s important to note that people with severe mental health issues or difficulties understanding the study will not be able to participate. This trial is currently recruiting participants, and everyone is welcome regardless of gender.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients aged from 0-50 years old
• • Patients with any illness or who will undergo any type of treatment that may cause irreversible damage to their fertility, such as extensive abdominal surgery, high toxicity medication and treatments;
• • Patients seek for fertility preservation services
• Exclusion Criteria:
• • -Patients unable to provide consent/assent (i.e. significant psychiatric problems/cognitive delay)